Education & Programming

 

Customize your ASNC2020 Virtual Experience

The unique format of this year's virtual meeting means you get the great education you've come to rely on ASNC for available when you need it. Create your own personalized educational experience with these sessions.*


Program Preview

Interactive Program Planner Now Available


Cases with the Aces
(Wednesdays in September and October)

CASE01 Cedars, Not the Tree (Cedars Sinai)
Wednesday, September 9, 2020 4:00pm - 5:30pm
 
CASE02 We the North: Hot cases from Cold Weather (Ottawa Heart Inst.)
Wednesday, September 16, 2020 4:00pm - 5:30pm
 
CASE03 Bread and Butter: Hold the Bread, Heavy on the MAYO
Wednesday, September 23, 2020 4:00pm - Saturday, September 26, 2020 4:00pm
 
CASE04 Gone with the Wind: Cases That Will Blow You Over (Cook County, Rush)
Wednesday, September 30, 2020 4:00pm - 5:30pm
 
CASE06 Cases from the University of Rochester
Wednesday, October 7, 2020 4:00pm - 5:30pm
 

Pre-Conference Special

Technological Advances and Innovation in Nuclear Cardiology: A Look into the Future, Part 1
PRE 1 Session - Thursday, September 24, 2020 10:00am - 11:00am
Moderators: Mehran Sadeghi, MD; I. George Zubal, PhD
  • 10:00AM - Novel SPECT technology - Ling Jian Meng, PhD
  • 10:15AM - New PET technology - Joel Karp, PhD
  • 10:30AM - Nuclear Imaging in the Interventional Suite - Albert J. Sinusas, MD, FASNC
  • 10:45AM - Discussion

Technological Advances and Innovation in Nuclear Cardiology: A Look into the Future, Part 2
PRE 2 Session  - Thursday, September 24, 2020 11:10am - 12:10pm
Moderators: Ernest V. Garcia, PhD, MASNC; Piotr J. Slomka, PhD, FASNC
  • 11:10AM - Novel Methods for Dynamic Cardiac SPECT Reconstruction - Chi Liu, PhD
  • 11:25AM - Low Dose SPECT Reconstruction Methods for Nuclear Cardiology - Michael A. King, PhD
  • 11:40AM - Advanced Strategies for PET Cardiac Quantitation - Georges El Fakhri, PhD
  • 11:55AM - Discussion

Technological Advances and Innovation in Nuclear Cardiology: A Look into the Future, Part 3
PRE 3 Session - Thursday, September 24, 2020 12:20pm - 1:20pm
Moderators: Simhan Danthi, PhD; Albert J. Sinusas, MD, FASNC
  • 12:20PM - Diagnostic Gaps and Related Biology in Contemporary CV Medicine - Mehran Sadeghi, MD
  • 12:35PM - Emerging Tracers for CV Molecular Imaging - Peter Caravan, PhD
  • 12:50PM - Barriers and Potential Solutions for Clinical Translation of Novel Tracers - Robert J. Gropler, MD, MASNC
  • 1:05PM - Discussion

NIH Panel Discussion: Technological Advances and Innovation in Nuclear Cardiology: A Look into the Future
PRE 4 Session - Thursday, September 24, 2020 1:30pm - 2:30pm
Moderators: Andrew E. Arai, MD; I. George Zubal, PhD
  • 1:30PM - Big picture! Early Engineering Work; New Technologies; Multi-organ Systems - Jill Heemskerk, PhD
  • 1:40PM - Vascular Inflammation, NHLBI, PET/CT & PET/MR and Other Imaging - Nehal Mehta, MD
  • 1:50PM - Research PET - Peter Herscovitch, MD
  • 2:00PM - PET Probe Development, Chemists - Robert J. Gropler, MD, MASNC
  • 2:10PM - Technology Initiatives (Radiotracers, Probes, Camera Development, Reconstruction) - Tatjana Atanasijevic, PhD
  • 2:20PM - Discussion
 

Plenary

118 - Mario Verani Lecture and Keynote Presentation
Friday, September 25, 2020 5:00pm - 6:30pm (ET)
  • President's Welcome
  • ASNC2020 Program Chair Welcome
  • Keynote Presentation: Clinical Applications of Artificial Intelligence in Nuclear Cardiology
  • Verani Lecture: Evolving Role of Nuclear Cardiology in CAD Management in the Era of Multimodality Imaging

101 - Presidents' Session and Awards Recognition
Friday, September 25, 2020 8:45am - 9:50am (ET)

Special

205 - COVID-19: Public Policy Update and Best Practices for Nuclear Cardiology
Saturday, September 26, 2020 10:30am - 11:20am (ET)
  • Public Policy Decision Making During the COVID-19 Pandemic
  • Best Practices for Nuclear Cardiology During the Pandemic

PET

103 - Clinical PET in CAD
Friday, September 25, 2020 10:15am - 11:30am (ET)
  • Cardiac PET in the Identification and Characterization of CAD Process and the Arteriolar Vessel
  • PET Perfusion and Flow Assessment - Can it Guide Revascularization Strategy in CAD
  • Appropriate Use Criteria (AUC) for PET MPI: A Short Overview
  • Considerations and Calculations to Establish a Cardiovascular PET Laboratory

111 - Expanding the Clinical Role of Quantitative MBF with PET
Friday, September 25, 2020 2:00pm - 3:30pm (ET)
  • Coronary Microvascular Disease: Diagnosis and Patient Management in 2020
  • How Can I be Sure that the Reduced MBF Reserve is Meaningful and not Artifactual?
  • Can MBF Measurements with PET Replace Invasive Coronary Angiography for Detection of Transplant Vasculopathy?
  • Can MBF Reserve Identify Patients with Asymptomatic Aortic Stenosis who Might Benefit from Earlier TAVR?

Advanced

201 - Imaging Innovations to Improve Outcomes
Saturday, September 26, 2020 9:00am - 10:15am
Measurement of Myocardial Blood Flow with CZT SPECT Systems
Radionuclide Imaging for Cardiac Dyssynchrony: Clinical Applications and Challenges
SPECT-CT PYP for Diagnosis of Cardiac Amyloidosis
Quantitative Perfusion SPECT and Artificial Intelligence for Enhanced Diagnosis and Prognosis
Discussion
 
209 - New Applications for PET Imaging
Saturday, September 26, 2020 2:15pm - 3:30pm
Technique for PET Imaging Microvascular Angina: Subendocardial blues?
Multimodality Approach to Plaque Imaging
PET Imaging for Predicting Arrhythmic Risk (HED and LMI1195 and Others)
Brain Heart Connection for Plaque Inflammation
Discussion


MOD02 - Clinical Hybrid Imaging
(Meeting on Demand Only)

FDG PET/CT Guided Diagnosis and Management of Cardiac Device Infections
Cardiovascular PET/MR: Hibernating, Viable or Dead on Arrival?
What's New in Digital PET/CT and Novel Attenuation Correction Techniques?
SPECT-CT Adding Calcium and Other Information from Attenuation Scans into Clinical Read
Discussion

Clinical Solutions for the Nuclear Cardiologist

105 - Challenging Cases in Nuclear SPECT Imaging
Friday, September 25, 2020 10:15am - 11:30am
“Scattering of the Photons” Imaging the Obese Patient Presenting for Pre-Op Cardiac Assessment Prior to Surgery Case Presentation followed by Discussion
“Rhythm Blues” What are the Options for Stress SPECT Imaging for Patients with Atrial Fibrillation and Rapid Ventricular Rates Case Presentation followed by Discussion
“ LocoMOTION” - Dealing with The Claustrophobic Patient, the Elderly Patient with Tremors and the Agitated Patient Case Presentation followed by Discussion
“ Special Cases” Stress Perfusion Imaging with SPECT in Patients with LVH due to HCM, Hypertensive Heart Disease, etc Case Presentation followed by Discussion
 
114 - Amyloid-Best Practices
Friday, September 25, 2020 3:30pm - 4:45pm
2020 Update: Trends of Community Adoption of Cardiac 99mTc-PYP Scintigraphy
Caution! Cardiac 99mTc-PYP Scintigraphy Increasingly Adopted but is Planar Imaging Sufficient? 1 or 3 hours? and⋯ Can we Track Disease Severity?
Cardiac 99mTc-PYP Scintigraphy: Not All TTR Glitters and Not All that Glitters is TTR
Leaps & Hurdles: Is PET Cardiac Amyloid Imaging Ready for Clinical Primetime Yet?
Discussion
 
203 - Taking your SPECT Lab to a Higher Level: Best Practices
Saturday, September 26, 2020 9:00am - 10:15am
What are the Dose Reduction Software and Hardware Options for the SPECT Lab: Solid State Cameras and Iterative Reconstruction Options for SPECT
Quantitative Analysis with SPECT to Improve Image Interpretation Including Avoiding Attenuation Artifacts on CZT Using 2-position Imaging.
Challenges Encountered in the Open Reading Nuclear SPECT Lab: How to Ensure Consistency and Quality of Service
The Importance of Correct Patient Instructions and Customization of Study Protocol for Patients- Who is Responsible? How to Ensure Consistency and Accuracy of Instructions: Technicians Perspective
The Importance of Correct Patient Instructions and Customization of Study Protocol for Patients- Who is Responsible? How to Ensure Consistency and Accuracy of Instructions: Physicians Perspective
Discussion
 
MOD01 - Hot Spot Imaging with FDG
(Meeting on Demand Only)
Viable ... To Be or Not To Be (How to Perform and Interpret FDG Myocardial Viability Studies: How Much Viability is Enough)
It's all About the Uptake (How to Perform and Interpret FDG PET Studies for Sarcoidosis: Quantification of FDG Uptake Matters)
Is it an Infection? FDG to the Rescue (Evolving Clinical Role of FDG PET/CT for Suspected Prosthetic Valve Endocarditis: Illustrative Cases)  
What the Heck is an SUV (Clinical Utility and Pitfalls of FDG PET/CT for Suspected CIED or LVAD Infections)
Discussion

Intersocietal Multimodality Imaging

116 - Vulnerable Plaque Imaging Coronary and Carotid Atherosclerosis (Joint Session with SCMR)
Friday, September 25, 2020 3:30pm - 4:45pm
F-18 NaF Assessment of Activity of Calcification
Hybrid PET/CT Imaging of Plaque
Coronary CTA for Coronary Plaque Quantitation and Characterization
CMR in Assessment of Carotid and Coronary Plaque
Discussion
 
202 - Calcium Scoring: Clinical Applications in Nuclear Cardiology and Beyond (Joint Session with SCCT)
Saturday, September 26, 2020 9:00am - 10:15am
Role of CAC Scoring in Preventive Cardiology
How to Use CAC Scoring as a Gatekeeper to Functional Testing
Adding CAC to SPECT and PET
How to Manage the Asymptomatic Patient with CAC>1000
Discussion
 
210 - Selecting Between Different Functional Tests
Saturday, September 26, 2020 2:15pm - 3:30pm
Strengths and Limitations of Lesion Specific Ischemia Versus Myocardial Ischemia
Comparing the Diagnostic Accuracy of CT-FFR, SPECT, and PET
The Role of Ischemia Testing in Patients with Non-obstructive CAD: CMR vs. PET
Putting it all Together: How to Select the Best Non-invasive Imaging Test to Evaluate for Ischemia
Discussion
 
MOD06 - Advanced Cardiac Imaging for Cardiac Sarcoidosis: How to Choose Better
(Meeting on Demand Only)
The Role of MRI in Cardiac Sarcoidosis
The role of PET/CT in Cardiac Sarcoidosis
How a Cardiac Sarcoid Specialist Integrates Multimodality Imaging
Case Presentations
Discussion

Image-based Case Management (Meeting on Demand Only)
Case presentations followed by panel discussion

  • MOD03 Integrating CTAC Data in SPECT/CT and PET/CT: Their Complementary Role with CTA
  • MOD04 Advanced Imaging in Complex Cases: Added Cost or Added Value
  • MOD05 Heart Failure/Chronic CAD
  • MOD07 Advanced Imaging in Complex Cases: PET Imaging in Non-ischemic Heart Disease
 
*Sessions subject to change

Overall Goals and Objectives

In order to maintain competence and improve performance, imaging professionals must assimilate and integrate knowledge spanning multiple areas, including clinical data, technical aspects of imaging, and appropriate application of imaging (e.g., clinical guidelines and appropriate use criteria).  Each of these areas is constantly evolving, particularly as innovative technologies and novel pharmacologic agents are introduced. ASNC2020 is an educational activity designed to help you and other imaging professionals obtain the latest information in clinical practice and review cutting-edge scientific advances in nuclear cardiology and cardiac imaging.

Target Audience
This course is intended for cardiologists, radiologists, nuclear medicine specialists, practice administrators, nuclear technologists, nurses, and other health care professionals with an interest in the field of nuclear cardiology and cardiac CT imaging.

Learner Objectives
After participating in this activity, learners will be able to:
  • Demonstrate improved skills in image interpretation and reporting
  • Learn how to recognize and minimize technical problems and artifacts that may be associated with cardiac imaging
  • Learn the appropriate use of cardiac imaging techniques based on current guidelines
  • Evaluate new imaging technologies, software, and stress techniques
  • Understand the role of nuclear and cardiac CT imaging in overall patient care
  • Learn the importance of balancing radiation exposure with image quality
  • Describe future directions in cardiac PET, CT and SPECT/CT in order to anticipate training and equipment needs
  • Understand the clinical implication of CT coronary angiography cases and recognize its value and limitations in clinical cardiology
This program design includes:
  • A scientific forum featuring panel discussions on focused areas of cutting-edge research
  • State-of-the-art reviews of the key aspects of nuclear cardiology by the world's experts
  • A basic core curriculum addressing practical issues in the performance of nuclear cardiology procedures to include opportunities for maintenance of certification credit
  • Scientific sessions on advances in nuclear cardiology
  • Ethics session will offer case based scenarios dealing with ethical issues
  • Educational track dealing with the pathophysiology of multimodality imaging
  • Highlight sessions dealing with clinical value of pharmacologic PET
  • Presentations addressing technical issues in nuclear cardiology
  • Oral abstracts featuring the latest clinical studies in cardiovascular imaging
  • Abstracts of original investigation programmed as eposter presentations
  • Commercial exhibits displaying the latest in nuclear cardiology technology and services
  • Cost-related information in the practice and business of nuclear cardiology
  • Opportunities to convene and interact with experts in all aspects of nuclear cardiology and cardiovascular imaging
  • The latest information on health policy reform

Credits

Physicians: The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Nuclear Cardiology designates the live and on demand activity for 55+* AMA PRA Category 1 Credits™and 30* ABIM MOC points. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Technologists: The American Society of Nuclear Cardiology is a recognized provider of continuing education credit for technologists. ASNC’s Continuing Education credit is accepted by both NMTCB and ARRT. ASNC2020 has been approved for a maximum of 30* ARRT Category A Credits for the live sessions only

Physician Assistants: The American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits from organizations accredited by ACCME.

Nurse Practitioners: The American Academy of Nurse Practitioners Certification Board (AANPCP) recognizes attendance at CE offerings which provide AMA PRA Category 1 Credits for the purpose of recertification.

Maintenance of Certification:CMEMOC
Successful completion of this CME activity enables the participant to earn up to 30* medical knowledge Maintenance of Certification (MOC) points in the American Board of Internal Medicine (ABIM) MOC program. Participants will earn MOC points equivalent to the amount of CME for the live activity only. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

*Credits subject to change. MOC and ARRT available for live sessions only. CME available for live and on demand sessions.​



ASNC has received the highest level of recognition, Accreditation with Commendation, from the Accreditation Council for Continuing Medical Education (ACCME). Accreditation with Commendation is awarded to CME providers that demonstrate compliance in all aspects of accreditation requirements and for demonstrating exemplary engagement with the environment in support of physician learning and physician quality improvement.
 

 

Statement of Need

Radionuclide-based cardiac imaging studies, including myocardial perfusion imaging (MPI), play an important role in the diagnosis and management of patients with known or suspected heart disease. Today more than 5000 laboratories are performing an estimated 8 million myocardial perfusion studies of which 58% use pharmacological stress agents, either alone with exercise. [DAIC 2013] A large body of scientific evidence exists on the clinical value of MPI, based on studies performed on many thousands of patients. These studies are highly sensitive and specific for the diagnosis, prognosis, and treatment response of coronary artery disease, as well as for selection of patients who may benefit from other types of intervention, including revascularization and device therapy. The value and justification of MPI for risk assessment is based on large observational outcome studies. As a result of the recognized clinical value and cost-effectiveness of these studies, they have been incorporated into many ACC/American Heart Association (AHA)/ASNC clinical management guidelines.

Nuclear cardiology is an evolving field with continuing advances in software, instrumentation and radiopharmaceuticals to provide high quality clinically relevant information for patient care. These advances require those involved in the providing nuclear cardiology studies to be continuously updated to ensure that the procedures are used appropriately and safely and that recent clinical and technological advances are incorporated in a timely manner to continue to improve the image quality and interpretation to provide the best clinical care.

Statement of Need and Learning Gaps